Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

RABOLIV-DSR

Class 5Status: Opposed
Trademark Logo
Application Number5340185
Trademark Status
Opposed
Trademark Class5
Application Date2022-02-22
Proprietor NameTAUFIQUE AHMAD KHAN TRADING AS OLIVEWELLNESS.
Appropriate OfficeDELHI
StateUTTARAKHAND
Trademark TypeDEVICE
User Details07/02/2022
Agent NameDELHI REGISTRATION SERVICE[34788]
Agent AddressS-104, 1ST FLOOR, PANCHSHEEL PARK, NEW DELHI-110017, INDIA
Goods And Services Details[CLASS : 5] medicinal and pharmaceutical preparations.

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
RABOLIV-DSR5Opposed
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about RABOLIV DSR.

What is the status of trademark application 5340185?
The current status of trademark application 5340185 for RABOLIV-DSR is Opposed.
What is the trademark class of RABOLIV-DSR?
RABOLIV-DSR is registered under trademark class 5.
Who is the proprietor of RABOLIV-DSR?
The proprietor of RABOLIV-DSR is TAUFIQUE AHMAD KHAN TRADING AS OLIVEWELLNESS..
When was trademark application 5340185 filed?
Trademark application 5340185 for RABOLIV-DSR was filed on 2022-02-22.